Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Itaconate drives mtRNA-mediated type I interferon production through inhibition of succinate dehydrogenase

  • O’Carroll, Shane M.
  • Peace, Christian G.
  • Toller-Kawahisa, Juliana E.
  • Min, Yukun
  • Hooftman, Alexander
  • Charki, Sara
  • Kehoe, Louise
  • O’Sullivan, Maureen J.
  • Zoller, Aline
  • Mcgettrick, Anne F.
  • Zotta, Alessia
  • Day, Emily A.
  • Simarro-Grande, María
  • Armstrong, Neali
  • Annes, Justin P.
  • O’Neill, Luke A. J.
Itaconate is one of the most highly upregulated metabolites in inflammatory macrophages and has been shown to have immunomodulatory properties. Here, we show that itaconate promotes type I interferon production through inhibition of succinate dehydrogenase (SDH). Using pharmacological and genetic approaches, we show that SDH inhibition by endogenous or exogenous itaconate leads to double-stranded mitochondrial RNA (mtRNA) release, which is dependent on the mitochondrial pore formed by VDAC1. In addition, the double-stranded RNA sensors MDA5 and RIG-I are required for IFNβ production in response to SDH inhibition by itaconate. Collectively, our data indicate that inhibition of SDH by itaconate links TCA cycle modulation to type I interferon production through mtRNA release., L.A.J.O. was funded by the European Research Council (Metabinnate 834370) and the Science Foundation Ireland (20/SPP/3685). The Simarro lab is funded by (1) Agencia Estatal de Investigación, Grant Number PID2020-118517RB-I00, and (2) Programa Estratégico Instituto de Biomedicina y Genética Molecular (IBGM), Junta de Castilla y León, Award Number CCVC8485., Peer reviewed